Differential regulation of HIC1 target genes by CtBP and NuRD, via an acetylation/SUMOylation switch, in quiescent versus proliferating cells

Molecular and Cellular Biology

Volumn 30, Issue 16, 2010, Pages 4045-4059

  Van Rechem, Capucine ^a,b   Boulay, Gaylor ^a   Pinte, Sébastien ^a   Stankovic Valentin, Nicolas ^a,c   Guérardel, Cateline ^a   Leprince, Dominique ^a  

^a UNIV LILLE   (France)

^b MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

^c UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEIN CTBP; PROTEIN NURD; PROTEIN P53; REPRESSOR PROTEIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR E2F1; TRANSCRIPTION FACTOR HIC1; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; GENE TARGETING; HIC1 GENE; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN PROCESSING; SUMOYLATION; TRANSCRIPTION REGULATION; TUMOR SUPPRESSOR GENE;

EID: 77955616940     PISSN: 02707306     EISSN: 10985549     Source Type: Journal    
DOI: 10.1128/MCB.00582-09     Document Type: Article

References (72)

1. Bereshchenko, O. R., W. Gu, and R. Dalla-Favera. 2002. Acetylation inactivates the transcriptional repressor BCL6. Nat. Genet. 32:606-613.
2. Besson, A., S. F. Dowdy, and J. M. Roberts. 2008. CDK inhibitors: cell cycle regulators and beyond. Dev. Cell 14:159-169. (Pubitemid 351189186)
3. Bowen, N. J., N. Fujita, M. Kajita, and P. A. Wade. 2004. Mi-2/NuRD: multiple complexes for many purposes. Biochim. Biophys. Acta 1677:52-57.
4. Briggs, K. J., I. M. Corcoran-Schwartz, W. Zhang, T. Harcke, W. L. Devereux, S. B. Baylin, C. G. Eberhart, and D. N. Watkins. 2008. Cooperation between the Hic1 and Ptch1 tumor suppressors in medulloblastoma. Genes Dev. 22:770-785.
5. Britschgi, C., M. Rizzi, T. J. Grob, M. P. Tschan, B. Hugli, V. A. Reddy, A. C. Andres, B. E. Torbett, A. Tobler, and M. F. Fey. 2006. Identification of the p53 family-responsive element in the promoter region of the tumor suppressor gene hypermethylated in cancer 1. Oncogene 25:2030-2039.
6. Carter, M. G., M. A. Johns, X. Zeng, L. Zhou, M. C. Zink, J. L. Mankowski, D. M. Donovan, and S. B. Baylin. 2000. Mice deficient in the candidate tumor suppressor gene Hic1 exhibit developmental defects of structures affected in the Miller-Dieker syndrome. Hum. Mol. Genet. 9:413-419.
7. Chen, W. Y., X. Zeng, M. G. Carter, C. N. Morrell, R. W. Chiu Yen, M. Esteller, D. N. Watkins, J. G. Herman, J. L. Mankowski, and S. B. Baylin. 2003. Heterozygous disruption of Hic1 predisposes mice to a gender-dependent spectrum of malignant tumors. Nat. Genet. 33:197-202.
8. Chen, W. Y., D. H. Wang, R. C. Yen, J. Luo, W. Gu, and S. B. Baylin. 2005. Tumor suppressor HIC1 directly regulates SIRT1 to modulate p53-dependent DNA-damage responses. Cell 123:437-448.
9. Kip1 CDK 'inhibitors' are essential activators of cyclin D-dependent kinases in murine fibroblasts. EMBO J. 18:1571-1583.
10. Chinnadurai, G. 2007. Transcriptional regulation by C-terminal binding proteins. Int. J. Biochem. Cell Biol. 39:1593-1607.
11. Ci, W., J. M. Polo, and A. Melnick. 2008. B-cell lymphoma 6 and the molecular pathogenesis of diffuse large B-cell lymphoma. Curr. Opin. Hematol. 15:381-390.
12. Crook, J. M., N. R. Dunn, and A. Colman. 2006. Repressed by a NuRD. Nat. Cell Biol. 8:212-214.
13. Dahl, J. A., and P. Collas. 2007. Q2ChIP, a quick and quantitative chromatin immunoprecipitation assay, unravels epigenetic dynamics of developmentally regulated genes in human carcinoma cells. Stem Cells 25:1037-1046.
14. KIP2 and c-Myc expression. Oncogene 20:3258-3265.
15. Dehennaut, V., and D. Leprince. 2009. Implication of HIC1 (hypermethylated in cancer 1) in the DNA damage response. Bull. Cancer 96:E66-E72.
16. Deltour, S., C. Guerardel, and D. Leprince. 1999. Recruitment of SMRT/N-CoR-mSin3A-HDAC-repressing complexes is not a general mechanism for BTB/POZ transcriptional repressors: the case of HIC-1 and γFBP-B. Proc. Natl. Acad. Sci. U. S. A. 96:14831-14836.
17. Deltour, S., S. Pinte, C. Guerardel, B. Wasylyk, and D. Leprince. 2002. The human candidate tumor suppressor gene HIC1 recruits CtBP through a degenerate GLDLSKK motif. Mol. Cell. Biol. 22:4890-4901.
18. Denslow, S. A., and P. A. Wade. 2007. The human Mi-2/NuRD complex and gene regulation. Oncogene 26:5433-5438. (Pubitemid 47255925)
19. Diella, F., S. Chabanis, K. Luck, C. Chica, C. Ramu, C. Nerlov, and T. J. Gibson. 2009. KEPE: a motif frequently superimposed on sumoylation sites in metazoan chromatin proteins and transcription factors. Bioinformatics 25:1-5.
20. Fleuriel, C., M. Touka, G. Boulay, C. Guerardel, B. R. Rood, and D. Leprince. 2009. HIC1 (hypermethylated in cancer 1) epigenetic silencing in tumors. Int. J. Biochem. Cell Biol. 41:26-33.
21. Fujita, N., D. L. Jaye, C. Geigerman, A. Akyildiz, M. R. Mooney, J. M. Boss, and P. A. Wade. 2004. MTA3 and the Mi-2/NuRD complex regulate cell fate during B lymphocyte differentiation. Cell 119:75-86.
22. Geiss-Friedlander, R., and F. Melchior. 2007. Concepts in sumoylation: a decade on. Nat. Rev. Mol. Cell. Biol. 8:947-956.
23. Gill, G. 2005. Something about SUMO inhibits transcription. Curr. Opin. Genet. Dev. 15:536-541.
24. Guerardel, C., S. Deltour, S. Pinte, D. Monte, A. Begue, A. K. Godwin, and D. Leprince. 2001. Identification in the human candidate tumor suppressor gene HIC-1 of a new major alternative TATA-less promoter positively regulated by p53. J. Biol. Chem. 276:3078-3089.
25. Hay, R. T. 2005. SUMO: a history of modification. Mol. Cell 18:1-12.
26. Hecker, C. M., M. Rabiller, K. Haglund, P. Bayer, and I. Dikic. 2006. Specification of SUMO1- and SUMO2-interacting motifs. J. Biol. Chem. 281:16117-16127.
27. Jenal, M., E. Trinh, C. Britschgi, A. Britschgi, V. Roh, S. A. Vorburger, A. Tobler, D. Leprince, M. F. Fey, K. Helin, and M. P. Tschan. 2009. The tumor suppressor gene hypermethylated in cancer 1 is transcriptionally regulated by E2F1. Mol. Cancer Res. 7:916-922.
28. Kaji, K., I. M. Caballero, R. MacLeod, J. Nichols, V. A. Wilson, and B. Hendrich. 2006. The NuRD component Mbd3 is required for pluripotency of embryonic stem cells. Nat. Cell Biol. 8:285-292.
29. Kumar, R., R. A. Wang, and R. Bagheri-Yarmand. 2003. Emerging roles of MTA family members in human cancers. Semin. Oncol. 30:30-37.
30. Kwon, H. S., and M. Ott. 2008. The ups and downs of SIRT1. Trends Biochem. Sci. 33:517-525.
31. LaBaer, J., M. D. Garrett, L. F. Stevenson, J. M. Slingerland, C. Sandhu, H. S. Chou, A. Fattaey, and E. Harlow. 1997. New functional activities for the p21 family of CDK inhibitors. Genes Dev. 11:847-862.
32. Lauberth, S. M., and M. Rauchman. 2006. A conserved 12-amino acid motif in Sall1 recruits the nucleosome remodeling and deacetylase corepressor complex. J. Biol. Chem. 281:23922-23931.
33. Lauberth, S. M., A. C. Bilyeu, B. A. Firulli, K. L. Kroll, and M. Rauchman. 2007. A phosphomimetic mutation in the Sall1 repression motif disrupts recruitment of the nucleosome remodeling and deacetylase complex and repression of Gbx2. J. Biol. Chem. 282:34858-34868.
34. Le Guezennec, X., M. Vermeulen, A. B. Brinkman, W. A. Hoeijmakers, A. Cohen, E. Lasonder, and H. G. Stunnenberg. 2006. MBD2/NuRD and MBD3/NuRD, two distinct complexes with different biochemical and functional properties. Mol. Cell. Biol. 26:843-851.
35. Liang, J., M. Wan, Y. Zhang, P. Gu, H. Xin, S. Y. Jung, J. Qin, J. Wong, A. J. Cooney, D. Liu, and Z. Songyang. 2008. Nanog and Oct4 associate with unique transcriptional repression complexes in embryonic stem cells. Nat. Cell Biol. 10:731-739.
36. 1/S cell cycle progression through bidirectional regulation of cyclins and cyclin-dependent kinase inhibitors via the phosphatidylinositol 3-kinase/Akt pathway in developing rat cerebral cortex. J. Neurosci. 29:775-788.
37. Manavathi, B., and R. Kumar. 2007. Metastasis tumor antigens, an emerging family of multifaceted master coregulators. J. Biol. Chem. 282:1529-1533.
38. McDonel, P., I. Costello, and B. Hendrich. 2009. Keeping things quiet: roles of NuRD and Sin3 co-repressor complexes during mammalian development. Int. J. Biochem. Cell Biol. 41:108-116.
39. Mendez, L. M., J. M. Polo, J. J. Yu, M. Krupski, B. B. Ding, A. Melnick, and B. H. Ye. 2008. CtBP is an essential corepressor for BCL6 autoregulation. Mol. Cell. Biol. 28:2175-2186.
40. Messner, S., D. Schuermann, M. Altmeyer, I. Kassner, D. Schmidt, P. Schar, S. Muller, and M. O. Hottiger. 2009. Sumoylation of poly(ADP-ribose) polymerase 1 inhibits its acetylation and restrains transcriptional coactivator function. FASEB J. 23:3978-3989.
41. Milner, J. 2009. Cellular regulation of SIRT1. Curr. Pharm. Des. 15:39-44.
42. Morey, L., C. Brenner, F. Fazi, R. Villa, A. Gutierrez, M. Buschbeck, C. Nervi, S. Minucci, F. Fuks, and L. Di Croce. 2008. MBD3, a component of the NuRD complex, facilitates chromatin alteration and deposition of epigenetic marks. Mol. Cell. Biol. 28:5912-5923.
43. Nemoto, S., M. M. Fergusson, and T. Finkel. 2004. Nutrient availability regulates SIRT1 through a forkhead-dependent pathway. Science 306:2105-2108. (Pubitemid 40007664)
44. Ouyang, J., and G. Gill. 2009. SUMO engages multiple corepressors to regulate chromatin structure and transcription. Epigenetics 4:440-444.
45. Ouyang, J., Y. Shi, A. Valin, Y. Xuan, and G. Gill. 2009. Direct binding of CoREST1 to SUMO-2/3 contributes to gene-specific repression by the LSD1/CoREST1/HDAC complex. Mol. Cell 34:145-154.
46. Parekh, S., J. M. Polo, R. Shaknovich, P. Juszczynski, P. Lev, S. M. Ranuncolo, Y. Yin, U. Klein, G. Cattoretti, R. Dalla Favera, M. A. Shipp, and A. Melnick. 2007. BCL6 programs lymphoma cells for survival and differentiation through distinct biochemical mechanisms. Blood 110:2067-2074. (Pubitemid 47443924)
47. Pateras, I. S., K. Apostolopoulou, K. Niforou, A. Kotsinas, and V. G. Gorgoulis. 2009. p57KIP2: "Kipöing the cell under control. Mol. Cancer Res. 7:1902-1919.
48. Pinte, S., N. Stankovic-Valentin, S. Deltour, B. R. Rood, C. Guerardel, and D. Leprince. 2004. The tumor suppressor gene HIC1 (hypermethylated in cancer 1) is a sequence-specific transcriptional repressor: definition of its consensus binding sequence and analysis of its DNA binding and repressive properties. J. Biol. Chem. 279:38313-38324.
49. Roche, A. E., B. J. Bassett, S. A. Samant, W. Hong, G. A. Blobel, and E. C. Svensson. 2008. The zinc finger and C-terminal domains of MTA proteins are required for FOG-2-mediated transcriptional repression via the NuRD complex. J. Mol. Cell Cardiol. 44:352-360.
50. Rood, B. R., H. Zhang, D. M. Weitman, and P. H. Cogen. 2002. Hypermethylation of HIC-1 and 17p allelic loss in medulloblastoma. Cancer Res. 62:3794-3797.
51. Rytinki, M. M., and J. J. Palvimo. 2009. SUMOylation attenuates the function of PGC-1α. J. Biol. Chem. 284:26184-26193.
52. Sasaki, T., B. Maier, A. Bartke, and H. Scrable. 2006. Progressive loss of SIRT1 with cell cycle withdrawal. Aging Cell 5:413-422. (Pubitemid 44322537)
53. Schultz, D. C., J. R. Friedman, and F. J. Rauscher III. 2001. Targeting histone deacetylase complexes via KRAB-zinc finger proteins: the PHD and bromodomains of KAP-1 form a cooperative unit that recruits a novel isoform of the Mi-2α subunit of NuRD. Genes Dev. 15:428-443.
54. Sewing, A., C. Burger, S. Brusselbach, C. Schalk, F. C. Lucibello, and R. Muller. 1993. Human cyclin D1 encodes a labile nuclear protein whose synthesis is directly induced by growth factors and suppressed by cyclic AMP. J. Cell Sci. 104(Pt. 2):545-555. (Pubitemid 23098692)
55. Sherr, C. J., and J. M. Roberts. 1999. CDK inhibitors: positive and negative regulators of G1-phase progression. Genes Dev. 13:1501-1512.
56. Shi, Y., J. Sawada, G. Sui, B. Affar el, J. R. Whetstine, F. Lan, H. Ogawa, M. P. Luke, Y. Nakatani, and Y. Shi. 2003. Coordinated histone modifications mediated by a CtBP co-repressor complex. Nature 422:735-738.
57. Song, J., L. K. Durrin, T. A. Wilkinson, T. G. Krontiris, and Y. Chen. 2004. Identification of a SUMO-binding motif that recognizes SUMO-modified proteins. Proc. Natl. Acad. Sci. U. S. A. 101:14373-14378.
58. Stankovic-Valentin, N., A. Verger, S. Deltour-Balerdi, K. G. Quinlan, M. Crossley, and D. Leprince. 2006. A L225A substitution in the human tumour suppressor HIC1 abolishes its interaction with the corepressor CtBP. FEBS J. 273:2879-2890. (Pubitemid 43910043)
59. Stankovic-Valentin, N., S. Deltour, J. Seeler, S. Pinte, G. Vergoten, C. Guerardel, A. Dejean, and D. Leprince. 2007. An acetylation/deacetylation- SUMOylation switch through a phylogenetically conserved psiKXEP motif in the tumor suppressor HIC1 regulates transcriptional repression activity. Mol. Cell. Biol. 27:2661-2675.
60. Tokino, T., T. Urano, T. Furuhata, M. Matsushima, T. Miyatsu, S. Sasaki, and Y. Nakamura. 1996. Characterization of the human p57KIP2 gene: alternative splicing, insertion/deletion polymorphisms in VNTR sequences in the coding region, and mutational analysis. Hum. Genet. 97:625-631.
61. Van Rechem, C., G. Boulay, and D. Leprince. 2009. HIC1 interacts with a specific subunit of SWI/SNF complexes, ARID1A/BAF250A. Biochem. Biophys. Res. Commun. 385:586-590.
62. Van Rechem, C., B. R. Rood, M. Touka, S. Pinte, M. Jenal, C. Guerardel, K. Ramsey, D. Monte, A. Begue, M. P. Tschan, D. A. Stephan, and D. Leprince. 2009. Scavenger chemokine (CXC motif) receptor 7 (CXCR7) is a direct target gene of HIC1 (hypermethylated in cancer 1). J. Biol. Chem. 284:20927-20935.
63. Verger, A., J. Perdomo, and M. Crossley. 2003. Modification with SUMO: a role in transcriptional regulation. EMBO Rep. 4:137-142. (Pubitemid 36322153)
64. Vo, N., C. Fjeld, and R. H. Goodman. 2001. Acetylation of nuclear hormone receptor-interacting protein RIP140 regulates binding of the transcriptional corepressor CtBP. Mol. Cell. Biol. 21:6181-6188.
65. Wales, M. M., M. A. Biel, W. el Deiry, B. D. Nelkin, J. P. Issa, W. K. Cavenee, S. J. Kuerbitz, and S. B. Baylin. 1995. p53 activates expression of HIC-1, a new candidate tumour suppressor gene on 17p13.3. Nat. Med. 1:570-577.
66. Wang, C., L. Chen, X. Hou, Z. Li, N. Kabra, Y. Ma, S. Nemoto, T. Finkel, W. Gu, W. D. Cress, and J. Chen. 2006. Interactions between E2F1 and SirT1 regulate apoptotic response to DNA damage. Nat. Cell Biol. 8:1025-1031.
67. Yan, Y., J. Frisen, M. H. Lee, J. Massague, and M. Barbacid. 1997. Ablation of the CDK inhibitor p57Kip2 results in increased apoptosis and delayed differentiation during mouse development. Genes Dev. 11:973-983. (Pubitemid 27199877)
68. Yang, S. H., and A. D. Sharrocks. 2004. SUMO promotes HDAC-mediated transcriptional repression. Mol. Cell 13:611-617. (Pubitemid 38299387)
69. Yang, Y., W. Fu, J. Chen, N. Olashaw, X. Zhang, S. V. Nicosia, K. Bhalla, and W. Bai. 2007. SIRT1 sumoylation regulates its deacetylase activity and cellular response to genotoxic stress. Nat. Cell Biol. 9:1253-1262.
70. Zhang, Q., S. Y. Wang, C. Fleuriel, D. Leprince, J. V. Rocheleau, D. W. Piston, and R. H. Goodman. 2007. Metabolic regulation of SIRT1 transcription via a HIC1:CtBP corepressor complex. Proc. Natl. Acad. Sci. U. S. A. 104:829-833.
71. Zhang, B., K. J. Chambers, D. Leprince, D. V. Faller, and S. Wang. 2009. Requirement for chromatin-remodeling complex in novel tumor suppressor HIC1-mediated transcriptional repression and growth control. Oncogene 28:651-661.
72. Zhang, W., X. Zeng, K. J. Briggs, R. Beaty, B. Simons, R. W. Chiu Yen, M. A. Tyler, H. C. Tsai, Y. Ye, G. S. Gesell, J. G. Herman, S. B. Baylin, and D. N. Watkins. 2010. A potential tumor suppressor role for Hic1 in breast cancer through transcriptional repression of ephrin-A1. Oncogene 29:2467-2476.